ABSCI CORPORATION - COMMON STOCK

Absci to Participate in the Canaccord Genuity 43rd Annual Growth Conference

26 июл 2023 08:00:00 Источник Nasdaq GlobeNewswire

Absci to Participate in the Morgan Stanley 2nd Annual Biotechnology AI Summit

15 июн 2023 08:00:00 Источник Nasdaq GlobeNewswire

Absci Evolves its Board of Directors with HealthTech Luminary Frans van Houten, Former CEO of Philips

06 июн 2023 08:00:02 Источник Nasdaq GlobeNewswire

Absci Reports Business Updates and First Quarter 2023 Financial and Operating Results

15 май 2023 16:05:00 Источник Nasdaq GlobeNewswire

University of Oxford’s Kennedy Institute of Rheumatology Partners with Absci to Accelerate AI-Driven Immunotherapies

11 май 2023 08:00:01 Источник Nasdaq GlobeNewswire

Absci to Participate in the 22nd Annual Needham Virtual Healthcare Conference

06 апр 2023 08:00:00 Источник Nasdaq GlobeNewswire

Absci Partners with Bioinformatics Company M2GEN to Accelerate Drug Creation for Oncology

04 апр 2023 08:00:00 Источник Nasdaq GlobeNewswire

Absci Reports Fourth Quarter and Full Year 2022 Financial and Operating Results

30 мар 2023 16:05:00 Источник Nasdaq GlobeNewswire

Absci to Participate in the B. Riley Securities' Life Sciences Tools Conference - Proteomics Setting the Blueprint for Innovative Drug Creation

23 мар 2023 08:00:00 Источник Nasdaq GlobeNewswire

Absci to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

07 мар 2023 08:00:01 Источник Nasdaq GlobeNewswire

Absci Expands in Europe with Launch of New Innovation Center and Additional Senior Leadership in Switzerland

28 фев 2023 08:00:01 Источник Nasdaq GlobeNewswire

Absci to Participate in the 43rd Annual Cowen Health Care Conference

21 фев 2023 08:00:02 Источник Nasdaq GlobeNewswire

St. John’s Cancer Institute Partners with Absci to Expedite Development of Cancer Therapies

09 фев 2023 08:00:01 Источник Nasdaq GlobeNewswire

Absci Deepens Scientific Advisory Board to Accelerate Generative AI Drug Creation

08 фев 2023 08:00:00 Источник Nasdaq GlobeNewswire

Absci First to Create and Validate De Novo Antibodies with Zero-Shot Generative AI

10 янв 2023 08:00:02 Источник Nasdaq GlobeNewswire

Absci to Participate in the 41st Annual J.P. Morgan Healthcare Conference

08 янв 2023 15:13:30 Источник Nasdaq GlobeNewswire

Absci to Participate in the 41st Annual J.P. Morgan Healthcare Conference

28 дек 2022 08:00:00 Источник Nasdaq GlobeNewswire

Absci to Participate in the Berenberg Discover AI Seminar

23 ноя 2022 08:00:00 Источник Nasdaq GlobeNewswire

Absci to Participate in the Stifel Healthcare Conference

02 ноя 2022 16:05:01 Источник Nasdaq GlobeNewswire

Absci Welcomes Meta Senior Executive to Board of Directors

02 ноя 2022 08:00:01 Источник Nasdaq GlobeNewswire